BioDrugs

Quality Considerations for Recombinant DNA-Derived Biological Therapeutic Products: A Control Perspective on Cytokines
pp. 367-376(10)
Authors: Mire-Sluis A.; Thorpe R.

Antiplatelet Drugs Plus Thrombolysis in Myocardial Infarction: Where Are We Now?
pp. 377-383(7)
Author: Vogt A.

Tolerability of Leukotriene Modifiers in Asthma: A Review of Clinical Experience
pp. 385-394(10)
Authors: Gozalo Reques F.; Estrada Rodriguez J.L.

Tacrolimus and Mycophenolate Mofetil Regimens in Transplantation: Benefits and Pitfalls
pp. 395-407(13)
Authors: Ciancio G.; Burke G.W.; Roth D.; Miller J.

Thalidomide: Current Uses
pp. 409-416(8)
Author: Powell R.J.

Recombinant Hirudin: Clinical Pharmacology and Potential Applications in Nephrology
pp. 417-429(13)
Authors: vanholder R.; Dhondt A.

Levosalbutamol
pp. 431-438(8)
Authors: Ormrod D.; Spencer C.M.

Levosalbutamol: A Viewpoint by Peter Black
pp. 439-440(2)
Author: Black P.

Levosalbutamol: A Viewpoint by Harold S. Nelson
pp. 439-440(2)
Author: Nelson H.S.